SCHEMBL2949467

SCHEMBL2949467

[CH2]C(C(=O)OC)c1nccs1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
PKM P14618 2/20 0.40
CTSA P10619 5/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PPARG P37231 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
BRD4 O60885 1/20 0.35
HTT P42858 1/20 0.35
PTPRB P23467 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27641754 0.84 ALDH1A1 (0.42) ALDH1A1PKMCTSANPC1RAB9A
SCHEMBL27815004 0.79 ALDH1A1 (0.43) ALDH1A1PKMCTSANPC1RAB9A
SCHEMBL29278491 0.78 CTSA (0.40) ALDH1A1CTSANPC1RAB9A
Hydrochloric Acid SCHEMBL5247586 0.78 ALDH1A1 (0.42) ALDH1A1PKMCTSANPC1RAB9A
SCHEMBL11188437 0.74 ALDH1A1 (0.36) ALDH1A1PKMCTSANPC1RAB9A
SCHEMBL27339458 0.72 TACR3 (0.39) ALDH1A1PKMCTSANPC1RAB9A
SCHEMBL28257842 0.71 CTSA (0.45) ALDH1A1CTSANPC1RAB9AL3MBTL1
SCHEMBL11275452 0.70 LMNA (0.33) ALDH1A1PKMCTSANPC1RAB9A
SCHEMBL24328848 0.70 CTSA (0.40) ALDH1A1CTSA
SCHEMBL8429804 0.70 ALDH1A1 (0.51) ALDH1A1PKMCTSANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139475-A2 THE USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS Omeros Corporation (US) 2010-01-06 EP disclosed
WO-2008119057-A2 THE USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS OMEROS CORPORATION (US) 2008-10-02 WO disclosed